MONOCLONAL-ANTIBODIES OF PREDEFINED SPECIFICITY DETECT ACTIVATED RAS GENE-EXPRESSION IN HUMAN MAMMARY AND COLON CARCINOMAS
MONOCLONAL-ANTIBODIES OF PREDEFINED SPECIFICITY DETECT ACTIVATED RAS GENE-EXPRESSION IN HUMAN MAMMARY AND COLON CARCINOMAS
复制标题
DOI:
10.1073/pnas.81.16.5227
复制
发表时间:
1984-01-01
期刊:
影响因子:
--
通讯作者:
SCHLOM, J
中科院分区:
文献类型:
--
作者:
HAND, PH;WUNDERLICH, ATD;SCHLOM, J
Monoclonal antibodies (MAb) of predefined specificity were generated by utilizing a synthetic peptide reflecting amino acid positions 10-17 of the Hu-rasT24 gene product as immunogen. These MAb, designated RAP-1 through RAP-5 (RA, ras; P, peptide), were shown to react with the ras gene product p21. Since the Hu-ras reactive determinants (positions 10-17) were predicted to be within the tertiary structure of the p21 molecule, it was not unexpected that denaturation of cell extracts or tissue sections with Formalin or glutaraldehyde enhanced binding of the RAP MAb. When paraffin-embedded Formalin-fixed tissue sections and the avidin-biotin complex immunoperoxidase method were used; the RAP MAb clearly defined enhanced ras p21 expression in the majority of human colon and mammary carcinomas. The majority of all abnormal ducts and lobules from fibroadenoma and fibrocystic disease patients were negative, as were all normal mammary and colonic epithelia examined. The findings reported here form the basis for quantitative radioimmmunoassays for a ras translational product and provide a means to evaluate ras p21 expression within individual cells of normal tissues and benign, premalignant, and malignant lesions.